December 11, 2018, Health Central  

Mayo Clinic researchers have found that the urinary incontinence medication oxybutynin (Oxytrol, Ditropan XL) can reduce the severity and frequency of hot flashes in menopausal women who aren't able to take hormone replacement therapy (HRT), including women who've had breast cancer. The researchers presented their findings at the 2018 San Antonio Breast Cancer Symposium.  

Read more.